Experimental evaluation of amylose succinate absorbable hemostat in a canine model.
Using a semiquantitative animal model of standardized injuries to parenchymatous organs resulting in a range of degrees of hemorrhage, we compared freeze-dried amylose succinate topical hemostat to the most widely used commercially available products. Hemostatic efficacy parameters included bleeding time, blood loss, incidence of rebleeding, and amount of material used. Although no material was consistently superior in all parameters, in general amylose succinate and microcrystalline collagen performed equally well and both were significantly more effective than oxidized regenerated cellulose. Both amylose succinate and oxidized regenerated cellulose were superior to microcrystalline collagen, however, in biodegradation time, inflammatory response and adhesion-forming potential. Details of the animal model and an adhesion grading scheme are presented.
Medical Device Research Division, American Cyanamid Co., Pearl River, New York 10965.
J K
JK
Largis
A R
AR
Katz
D000042:Absorption; D000688:Amylose / Q000494:pharmacology*; D000818:Animals; D001760:Bleeding Time; D004285:Dogs; D006488:Hemostasis, Surgical; D006490:Hemostatics / Q000494:pharmacology*; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D011183:Postoperative Complications; D000267:Tissue Adhesions
D006490:Hemostatics; D000688:Amylose